Amicus Therapeutics, a global biotechnology company focused on discovering, developing and delivering high-quality medicines for individuals with rare diseases, is set to participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV. The session is scheduled for Wednesday, May 15, 2024, at 1:40 p.m. P.T. Those interested can access a live audio webcast of the presentation through the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations
Amicus Therapeutics is listed on Nasdaq under the symbol FOLD and has a mission to advance and expand its pipeline of innovative medicines for rare diseases with a strong emphasis on meeting the needs of patients. To learn more about Amicus Therapeutics and its work in this area, visit their website at www.amicusrx.com or follow them on X and LinkedIn
For investor inquiries, please contact Andrew Faughnan, Vice President of Investor Relations at afaughnan@amicusrx.com or (609) 662-3809 . For media inquiries reach out to Diana Moore Head of Global Corporate Affairs and Communications at dmoore@amicusrx.com or (609) 662-5079